198 related articles for article (PubMed ID: 7507539)
21. [Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors].
Linz W; Busch AE
Pharm Unserer Zeit; 2003; 32(1):18-22. PubMed ID: 12577756
[No Abstract] [Full Text] [Related]
22. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
Hollenberg NK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
[TBL] [Abstract][Full Text] [Related]
25. Plasma renin activity and changes in tissue angiotensin converting enzyme.
Michel B; Grima M; Stephan D; Coquard C; Welsch C; Barthelmebs M; Imbs JL
J Hypertens; 1994 May; 12(5):577-84. PubMed ID: 7930558
[TBL] [Abstract][Full Text] [Related]
26. The renin-angiotensin system as a target for therapeutic intervention.
Swales JD
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
[TBL] [Abstract][Full Text] [Related]
27. Management of hypertension and its sequelae with ACE inhibitors: biochemical, pharmacological and clinical aspects.
Rangoonwala B; Rosenthal I
Int J Clin Pract; 1998 Oct; 52(7):492-500. PubMed ID: 10622092
[TBL] [Abstract][Full Text] [Related]
28. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
Tikkanen I; Johnston CI
Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
[TBL] [Abstract][Full Text] [Related]
29. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
Stajszczyk M; Gmiński J
Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
[TBL] [Abstract][Full Text] [Related]
31. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
[TBL] [Abstract][Full Text] [Related]
32. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
33. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
[TBL] [Abstract][Full Text] [Related]
35. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
37. [The renin-angiotensin-aldosterone system, angiotensin I converting enzyme, and the ACE-inhibitors. Historical perspective and recent findings].
Gensini GF; Lippi D; Conti AA
Recenti Prog Med; 2002 Oct; 93(10):544-53. PubMed ID: 12405014
[TBL] [Abstract][Full Text] [Related]
38. [Ramipril and cardiac and renal angiotensin converting enzyme].
Grima M; Stephan D; Welsch C; Coquard C; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():43-8. PubMed ID: 7646311
[TBL] [Abstract][Full Text] [Related]
39. [The importance of ACE2 in regulating the cardiovascular system].
Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
[TBL] [Abstract][Full Text] [Related]
40. [Combined blockade of the renin-angiotensin system].
Azizi M; Menard J
Arch Mal Coeur Vaiss; 1999 Jun; 92(6):735-9. PubMed ID: 10410812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]